← Evidence map

TrialInvestigational new drugs2006

A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma.

Karl D Lewis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

this papercites it

A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma. | OpenQuestion